BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35040075)

  • 1. The utility of surveillance CT scans in a cohort of survivors of colorectal cancer.
    Braden J; Blinman P; Malalasekera A; Kerin-Ayres K; Spencer J; Southi N; Vardy JL
    J Cancer Surviv; 2023 Aug; 17(4):1202-1210. PubMed ID: 35040075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
    Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
    Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
    Makis W; Kurzencwyg D; Hickeson M
    Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in post-operative surveillance testing for metastatic recurrence among colorectal cancer survivors.
    Sanchez JI; Shankaran V; Unger JM; Madeleine MM; Espinoza N; Thompson B
    J Cancer Surviv; 2022 Jun; 16(3):638-649. PubMed ID: 34031803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
    Nijhuis AAG; Dieng M; Khanna N; Lord SJ; Dalton J; Menzies AM; Turner RM; Allen J; Saw RPM; Nieweg OE; Thompson JF; Morton RL
    Ann Surg Oncol; 2019 Jun; 26(6):1860-1868. PubMed ID: 30911946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study?
    Mortazavi A; Shaukat A; Othman E; Kepner JL; Fakih MG; Kuvshinoff BW; Smith JL; Javle MM
    Am J Clin Oncol; 2005 Feb; 28(1):30-5. PubMed ID: 15685032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
    Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
    Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is early surveillance with CT scan necessary in patients with stage II/III colorectal cancer: a retrospective study.
    Liu GC; Tang JH; Wen SJ; Cao HX; An X; Cai PQ; Kong LH; Lin JZ; Li LR; Pan ZZ; Ding PR
    J Surg Oncol; 2013 Dec; 108(8):568-71. PubMed ID: 24105780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance patterns after curative-intent colorectal cancer surgery in Ontario.
    Tan J; Muir J; Coburn N; Singh S; Hodgson D; Saskin R; Kiss A; Paszat L; El-Sedfy A; Grunfeld E; Earle C; Law C
    Can J Gastroenterol Hepatol; 2014 Sep; 28(8):427-33. PubMed ID: 25014181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.
    Lee JH; Park CM; Joo I; Suh YJ; Hwang EJ; Kim H; Goo JM
    Eur Radiol; 2019 Aug; 29(8):4303-4314. PubMed ID: 30350166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
    J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in surveillance for resected colorectal cancer, 2001-2009.
    Paulson EC; Veenstra CM; Vachani A; Ciunci CA; Epstein AJ
    Cancer; 2015 Oct; 121(19):3525-33. PubMed ID: 26079928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Liver Ultrasound Useful as Part of the Surveillance Strategy following Potentially Curative Colorectal Cancer Resection?
    Schneider J; Koullouros M; Mackay C; Ramsay G; Parnaby C; Stevenson L
    Dig Dis; 2019; 37(3):234-238. PubMed ID: 30466102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
    Metser U; You J; McSweeney S; Freeman M; Hendler A
    AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
    Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
    Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
    Anannamcharoen S; Boonya-Ussadol C
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
    Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
    Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
    Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
    Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
    Zhang Y; Feng B; Zhang GL; Hu M; Fu Z; Zhao F; Zhang XL; Kong L; Yu JM
    World J Gastroenterol; 2014 Jun; 20(21):6608-14. PubMed ID: 24914384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a model to predict outcomes of colon cancer surveillance.
    Rose J; Homa L; Kong CY; Cooper GS; Kattan MW; Ermlich BO; Meyers JP; Primrose JN; Pugh SA; Shinkins B; Kim U; Meropol NJ
    Cancer Causes Control; 2019 Jul; 30(7):767-778. PubMed ID: 31129907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.